AstraZeneca Gets in on ADC Therapeutics' Mega $200M Funding Round Post author:Sam Post published:October 22, 2017 Post category:BioPharma ADC Therapeutics announced it had raised $200M through an oversubscribed private placement. Source: BioSpace You Might Also Like Rumors Surface M&A-Desperate Gilead is Nearing a Deal to Buy Incyte March 12, 2017 Pfizer Quietly Takes Passive Stake in This Boston Pharma October 18, 2017 AbbVie's PARP Inhibitor Fails to Deliver in Two Late-Stage Studies April 19, 2017